Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $8.5

Moomoo NewsFeb 10 06:32 ET · Ratings

Take Care Before Jumping Onto Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Even Though It's 25% Cheaper

Simply Wall StFeb 8 07:10 ET

RBC Capital Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsFeb 5 21:32 ET · Ratings

Aldevron Gains Access To Maravai LifeSciences' TriLink's CleanCap MRNA Technology For Non-Commercial Use; Agreement Boosts Access To Critical Therapeutic Development

BenzingaFeb 4 16:04 ET

Express News | Trilink Biotechnologies® and Aldevron Enter Into Non-Exclusive License and Supply Agreement for Cleancap® Mrna Capping Technology

ReutersFeb 4 16:01 ET

Maravai LifeSciences' TriLink BioTechnologies Partners With Avantor to Expand Nucleic Acid Product Availability in EMEA

MT NewswiresFeb 3 06:41 ET